查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球單位劑量包裝市場：按格式、按材料類型、按產品類型、按最終用途行業、按地區 - 預測至 2029 年
市場調查報告書
商品編碼
1527781

全球單位劑量包裝市場：按格式、按材料類型、按產品類型、按最終用途行業、按地區 - 預測至 2029 年

Unit Dose Packaging Market by Form (Liquid, Solid, Powder, Gel), Material Type (Plastic, Glass, Paper, Aluminium), Product Type, End-use industry (Pharmaceuticals, Cosmetic & Personal Care, Nutraceuticals), and Region - Global Forecast to 2029
出版日期: | 出版商: MarketsandMarkets | 英文 230 Pages | 訂單完成後即時交付

價格

單位劑量包裝市場規模預計將從 2024 年的 291 億美元成長到 2029 年的 438 億美元，預測期內複合年成長率為 8.5%。

由於泡殼包裝在確保藥品安全性、準確性和便利性方面具有顯著優勢，對泡殼包裝的需求不斷成長，顯著推動了單位劑量包裝市場的成長。泡殼包裝將單獨的劑量封裝在塑膠或箔隔間中，由於其能夠保護藥物免受潮濕和光照並保持效力，因此廣泛應用於製藥行業。避孕藥和非處方止痛藥等藥物通常採用泡殼包裝，以幫助患者輕鬆追蹤劑量並遵守用藥時間表。這種方法不僅可以提高患者的依從性，還可以透過清楚地分離和標記每個劑量來減少用藥錯誤。泡殼包裝的便利性使其成為生活方式忙碌的人們的理想選擇，使其更受歡迎。醫療保健產業對病人安全和用藥合規性的關注，以及泡殼包裝的實際好處，繼續推動其在各個行業的採用。

調查範圍
調查年份 2022-2029
基準年 2023年
預測期 2024-2029
考慮單位 金額（百萬美元）
部分 按形式、按材料類型、按產品類型、按最終用途行業、按地區
目標區域 北美、亞太地區、歐洲、南美、中東/非洲

固態單位劑量包裝佔很大佔有率，估計為 30-35%。這種包裝形式廣泛用於藥品，其中錠劑和膠囊的泡殼包裝很常見。Ibuprofen、抗組織胺藥物和綜合維他命等產品通常採用這種方式包裝，以確保劑量準確並免受環境因素影響。在食品領域，維生素和Omega-3膠囊等食品已採用固態單位劑量包裝，以提供方便和準確的劑量。化妝品也使用用於護膚的固態單位劑量包裝和含有面膜的一次性膠囊。固態單位劑量包裝的成長很大程度上是由其在製藥業的廣泛應用所推動的。

塑膠是透過連接各種構型的單體製成的合成材料，賦予它們獨特的性能，例如柔韌性、耐用性和抗劣化。在單位劑量包裝產業，聚乙烯 (PE)、聚丙烯 (PP) 和聚氯乙烯(PVC) 等塑膠被認為是防潮、防光、防氣體和防污染物的有效屏障。這些材料由於其精確的劑量能力、防篡改密封和易於打開的功能，在醫療保健和製藥領域非常重要，可確保安全和方便用戶使用的藥物傳輸。塑膠包裝具有成本效益，減少廢棄物，並符合嚴格的無菌和監管標準，有助於保持藥品安全有效。與玻璃或鋁相比，塑膠更輕、更耐衝擊、設計更靈活，可製成特殊形狀和尺寸，適合各種應用。

泡殼包裝由熱成型塑膠腔體和軟性頂部組成，旨在保護內容物免受濕氣、氣體、光線和物理損壞，從而保持完整性並延長保存期限。安全儲存單劑量藥物、維生素、補充品和其他產品。為了解決永續性問題，現代泡殼包裝採用環保材料和高效設計，最大限度地減少對環境的影響，同時滿足藥品、食品和醫療設備。泡殼包裝透過增強產品保護、確保準確劑量和提高安全性來提高包裝效率。

該報告研究了全球單位劑量包裝市場，包括按格式、材料類型、產品類型、最終用途行業、地區和參與市場的公司概況分類的趨勢。

目錄

第1章簡介

第2章調查方法

第3章執行摘要

第 4 章重要考察

第5章市場概況

  • 介紹
  • 市場動態

第6章 產業動態

  • 波特五力分析
  • 價值鏈分析
  • 貿易分析
  • 生成的 AI 對單位劑量包裝的影響
  • 總體經濟指標
  • 技術分析
  • 關稅和監管狀況
  • 案例研究分析
  • 影響客戶業務的趨勢和顛覆
  • 2024-2025年重大會議和活動
  • 主要相關人員和採購標準
  • 生態系分析
  • 專利分析
  • 價格分析

第7章單位劑量包裝市場（依格式）

  • 介紹
  • 液體
  • 固體的
  • 粉末
  • 凝膠

第8章單位劑量包裝市場（依材料類型）

  • 介紹
  • 塑膠
  • 玻璃
  • 紙板
  • 鋁
  • 其他

第9章單位劑量包裝市場（依產品類型）

  • 介紹
  • 泡殼包裝
  • 小袋帶狀包裝
  • 安瓿/管瓶
  • 其他

第10章單位劑量包裝市場（依最終用途產業）

  • 介紹
  • 藥品
  • 化妝品/個人護理
  • 營養食品
  • 其他

第11章單位劑量包裝市場（按地區）

  • 介紹
  • 亞太地區
  • 歐洲
  • 北美洲
  • 南美洲
  • 中東/非洲

第12章競爭格局

  • 概述
  • 主要參與企業的策略/秘密
  • 收益分析
  • 市場佔有率分析
  • 企業價值評估及財務指標
  • 產品/品牌比較分析
  • 企業評估矩陣：主要參與企業，2023
  • 企業評估矩陣：Start-Ups/小型企業，2023 年
  • 競爭格局及趨勢

第13章 公司簡介

  • 主要參與企業
    • PFIZER INC.
    • AMCOR PLC
    • CORNING INCORPORATED
    • WEST PHARMACEUTICAL SERVICES
    • STEVANATO GROUP
    • GERRESHEIMER AG
    • SCHOTT
    • NIPRO
    • CONSTANTIA FLEXIBLES
    • KLOCKNER PENTAPLAST
  • 其他公司
    • SONIC PACKAGING INDUSTRIES INC.
    • SHARP SERVICES, LLC
    • TEKNI-PLEX, INC.
    • THERMO-PAK CO. INC.
    • APHENA PHARMA SOLUTIONS
    • PACIFIC VIAL MANUFACTURING INC.
    • HEALTH CARE LOGISTICS, INC.
    • ULTRA SEAL CORPORATION
    • SAFECORE HEALTH
    • UNIT PACK
    • JONES HEALTHCARE GROUP
    • ROPACK INC.
    • RX SYSTEMS, INC.
    • JAMES ALEXANDER CORPORATION
    • PHARMACY AUTOMATION SUPPLIES

第14章 鄰近市場及相關市場

第15章附錄

Product Code: PK 9105

The unit dose packaging market is projected to grow from USD 29.1 Billion in 2024 to USD 43.8 Billion by 2029, at a CAGR of 8.5% during the forecast period. The rising demand for blister packaging is significantly driving the growth of the unit dose packaging market due to its key advantages in ensuring medication safety, accuracy, and convenience. Blister packaging, which encloses individual doses in plastic and foil compartments, is widely used in the pharmaceutical industry for its ability to protect medications from moisture and light, preserving their potency. Medications such as birth control pills and over-the-counter pain relievers are often packaged in blister packs, which help patients easily track doses and adhere to their medication schedules. This method not only improves patient compliance by clearly separating and labeling each dose but also reduces medication errors. The convenience of blister packaging makes it ideal for individuals with busy lifestyles, further boosting its popularity. The healthcare sector's emphasis on patient safety and adherence, along with the practical benefits of blister packaging, continues to drive its adoption across various industries.

Scope of the Report
Years Considered for the Study2022-2029
Base Year2023
Forecast Period2024-2029
Units ConsideredValue (USD Million)
SegmentsForm, Material Type, Product Type, End-Use Industry, and Region
Regions coveredNorth America, Asia Pacific, Europe, South America, and Middle East & Africa

"By Form, solid is the second largest market share for unit dose packaging during forecast period."

Solid unit dose packaging accounts for a substantial share, estimated at 30-35%. This packaging format is widely used in pharmaceuticals, where blister packs for tablets and capsules are common. Products such as ibuprofen, antihistamines, and multivitamins are frequently packaged in this way to ensure precise dosing and protection from environmental factors. In the nutraceutical sector, solid unit dose packaging is employed for vitamins and dietary supplements like Omega-3 capsules, providing convenience and accurate dosing. Cosmetics also use solid unit dose formats for items such as single-use capsules containing skincare treatments and face masks. The growth of solid unit dose packaging is largely driven by its extensive application in the pharmaceutical industry.

"By Material Type, plastic account for largest market share for unit dose packaging during forecast period."

Plastic, a synthetic material made by linking monomers in various configurations, offers unique properties like flexibility, durability, and resistance to degradation. In the unit dose packaging industry, plastics such as polyethylene (PE), polypropylene (PP), and polyvinyl chloride (PVC) are valued for their effective barriers against moisture, light, gases, and contaminants. These materials are crucial in healthcare and pharmaceuticals due to their precise dosing capabilities, tamper-evident seals, and easy-open features, ensuring secure and user-friendly medication delivery. Plastic packaging is cost-effective, reducing waste and meeting stringent sterility and regulatory standards, thus maintaining medication safety and efficacy. Compared to glass and aluminum, plastics are preferred for their lightweight nature, impact resistance, and design flexibility, accommodating specialized forms and sizes for various applications.

"By Product Type, blister pack account for largest share during forecast period."

Blister packs consist of a thermoformed plastic cavity and a flexible top, designed to protect contents from moisture, gases, light, and physical damage, thereby preserving their integrity and extending shelf life. They securely house individual doses of medications, vitamins, supplements, and other products. To address sustainability concerns, modern blister packs use eco-friendly materials and efficient designs to minimize environmental impact while meeting market needs in pharmaceuticals, nutraceuticals, and medical devices. Blister packs contribute to packaging efficiency by enhancing product protection, ensuring precise dosing, and increasing safety. Leading companies such as Amcor plc, Constantia Flexibles, and West Pharmaceutical Services are incorporating smart technologies like RFID (Radio Frequency Identification) and NFC (Near Field Communication) into blister packs to improve tracking, authentication, and real-time monitoring. Additionally, Klockner Pentaplast offers advanced films with high clarity, autoclavable laminate, and robust barriers against moisture and package leaching. These films are ideal for hot-fill liquids and new dosage forms, providing customizable moisture protection, high heat stability, quick release, and excellent odor and flavor retention.

"By End-Use Industry, Pharmaceutical End-use Industry Segment Accounted For largest share during forecast period."

Unit dose packaging is crucial in the pharmaceutical industry for distributing precise doses of medications, vitamins, oral liquids, and injectables. It ensures that each dose is securely contained in a sealed package, such as vials, ampoules, or blister packs. Technologies like Blow-Fill-Seal (BFS) streamline the sterile packaging process, minimizing contamination risks and enhancing product safety. The trend towards prefilled syringes and auto-injectors provides accurate dosing and improved patient compliance with added safety features. Innovations in sensors and indicators monitor environmental conditions to maintain medication efficacy. The shift towards sustainable materials and optimized packaging sizes highlights the industry's commitment to reducing environmental impact while enhancing patient safety and dosing accuracy.

"North America is accounted larget market for Unit dose packaging in 2023."

The North America region is accounted larget in the unit dose packaging market. This growth encompasses countries like US, Canada, and Mexico.

The unit dose packaging market in North America is being propelled by various factors. In North America, the pharmaceutical industry heavily relies on unit dose packaging for its precision, patient compliance, and protection against contamination and tampering. This demand is driven by a focus on patient-centric solutions, the need for accurate dosing to reduce errors, and the convenience of use. The aging population and high prevalence of chronic diseases further boost the need for pharmaceuticals and healthcare services. According to pharma association, in 2023, the industry invested around USD 90 billion in R&D, reflecting its growth. Stringent regulations by the FDA and Health Canada ensure compliance with safety and quality standards, influencing packaging choices. Despite significant growth, challenges such as increased competition, innovation, and environmental regulations pose constraints to the market.

In-depth interviews were conducted with Chief Executive Officers (CEOs), marketing directors, other innovation and technology directors, and executives from various key organizations operating in the unit dose packaging market.

  • By Company Type: Tier 1: 40%, Tier 2: 25%, and Tier 3: 35%
  • By Designation: C Level: 35%, Director Level: 30%, and Others: 35%
  • By Region: North America: 25%, Europe: 20%, APAC: 45%, Middle East & Africa: 5%, and South America: 5%

Companies Covered: The global unit dose packaging market comprises major manufacturers, such as Pfizer Inc. (US), Amcor Plc (Switzerland), Corning Incorporated (US), West Pharmaceutical Services (US), Stevanato Group (Italy), Gerresheimer AG (Germany), SCHOTT (Germany), Nipro (Japan), Constantia Flexibles (Austria), and Klockner Pentaplast (UK), among others.

Research Coverage

The market study covers the unit dose packaging market across various segments. It aims at estimating the market size and the growth potential of this market across different segments based on form, material type, product type, end-use industry, and region. The study also includes an in-depth competitive analysis of key players in the market, their company profiles, key observations related to their products and business offerings, recent developments undertaken by them, and key growth strategies adopted by them to improve their position in the unit dose packaging market.

Key Benefits of Buying the Report

The report is expected to help the market leaders/new entrants in this market share the closest approximations of the revenue numbers of the overall unit dose packaging market and its segments and sub-segments. This report is projected to help stakeholders understand the competitive landscape of the market, gain insights to improve the position of their businesses, and plan suitable go-to-market strategies. The report also aims to help stakeholders understand the pulse of the market and provides them with information on the key market drivers, challenges, and opportunities.

The report provides insights on the following pointers:

  • Analysis of key drivers (Thriving Pharmaceutical Sector and surge in healthcare expenditure, Rising demand for blister packaging, and Consumer preference for convenience and portability driving demand for unit dose packaging), restraints (The setup and maintenance of unit dose packaging machines and Environmental concerns), opportunities (Increasing demand for primary pharmaceutical packaging and Market expansion in nutraceuticals and cosmetics) and challenges (Technological challenges in the unit dose packaging market and High initial investment).
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the unit dose packaging market
  • Market Development: Comprehensive information about lucrative markets - the report analyses the unit dose packaging market across varied regions

Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the unit dose packaging market

  • Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players like Pfizer Inc. (US), Amcor Plc (Switzerland), Corning Incorporated (US), West Pharmaceutical Services (US), Stevanato Group (Italy), Gerresheimer AG (Germany), SCHOTT (Germany), Nipro (Japan), Constantia Flexibles (Austria), and Klockner Pentaplast (UK), among others in the unit dose packaging market. The report also helps stakeholders understand the pulse of the unit dose packaging market and provides them with information on key market drivers, restraints, challenges, and opportunities.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS AND EXCLUSIONS
  • 1.3 STUDY SCOPE
    • 1.3.1 UNIT DOSE PACKAGING MARKET SEGMENTATION
    • 1.3.2 YEARS CONSIDERED
    • 1.3.3 CURRENCY CONSIDERED
    • 1.3.4 UNITS CONSIDERED
  • 1.4 LIMITATIONS
  • 1.5 STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Key primary participants
      • 2.1.2.3 Key industry insights
      • 2.1.2.4 Breakdown of interviews with experts
  • 2.2 MARKET SIZE ESTIMATION
    • 2.2.1 BOTTOM-UP APPROACH
    • 2.2.2 TOP-DOWN APPROACH
  • 2.3 FORECAST NUMBER CALCULATION
  • 2.4 DATA TRIANGULATION
  • 2.5 FACTOR ANALYSIS
  • 2.6 ASSUMPTIONS
  • 2.7 RESEARCH LIMITATIONS AND RISKS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN UNIT DOSE PACKAGING MARKET
  • 4.2 NORTH AMERICA: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY AND COUNTRY
  • 4.3 NORTH AMERICA UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE
  • 4.4 NORTH AMERICA UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY
  • 4.5 UNIT DOSE PACKAGING MARKET, BY KEY COUNTRY

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Thriving pharmaceutical sector and surge in healthcare expenditure
      • 5.2.1.2 Rising demand for blister packaging
      • 5.2.1.3 Consumer preference for convenience and portability
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Substantial capital investment required for setup and maintenance of unit dose packaging machines
      • 5.2.2.2 Environmental concerns
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Increasing demand for primary pharmaceutical packaging
      • 5.2.3.2 Market expansion in nutraceuticals and cosmetics
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Technological challenges
      • 5.2.4.2 High initial investment

6 INDUSTRY TRENDS

  • 6.1 PORTER'S FIVE FORCES ANALYSIS
    • 6.1.1 THREAT OF NEW ENTRANTS
    • 6.1.2 THREAT OF SUBSTITUTES
    • 6.1.3 BARGAINING POWER OF SUPPLIERS
    • 6.1.4 BARGAINING POWER OF BUYERS
    • 6.1.5 INTENSITY OF COMPETITIVE RIVALRY
  • 6.2 VALUE CHAIN ANALYSIS
  • 6.3 TRADE ANALYSIS
    • 6.3.1 EXPORT SCENARIO
    • 6.3.2 IMPORT SCENARIO
  • 6.4 IMPACT OF GEN AI ON UNIT DOSE PACKAGING
    • 6.4.1 INTEGRATING AI IN UNIT DOSE PACKAGING
    • 6.4.2 BEST PRACTICES TO LEVERAGE AI FOR UNIT DOSE PACKAGING MARKET
    • 6.4.3 USE CASES OF GENERATIVE AI IN UNIT DOSE PACKAGING MARKET
      • 6.4.3.1 Future of generative AI in unit dose packaging market
  • 6.5 MACROECONOMIC INDICATORS
    • 6.5.1 GLOBAL GDP OUTLOOK
  • 6.6 TECHNOLOGY ANALYSIS
    • 6.6.1 KEY TECHNOLOGIES
      • 6.6.1.1 Blister packaging
      • 6.6.1.2 Strip packaging
      • 6.6.1.3 Blow-Fill-Seal
    • 6.6.2 COMPLEMENTARY TECHNOLOGIES
      • 6.6.2.1 Smart packaging
      • 6.6.2.2 Barrier and coating
  • 6.7 TARIFF AND REGULATORY LANDSCAPE
    • 6.7.1 TARIFF RELATED TO UNIT DOSE PACKAGING MARKET
    • 6.7.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 6.8 CASE STUDY ANALYSIS
  • 6.9 TRENDS AND DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • 6.10 KEY CONFERENCES & EVENTS IN 2024-2025
  • 6.11 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 6.11.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 6.11.2 BUYING CRITERIA
  • 6.12 ECOSYSTEM ANALYSIS
  • 6.13 PATENT ANALYSIS
    • 6.13.1 INTRODUCTION
    • 6.13.2 METHODOLOGY
  • 6.14 PRICING ANALYSIS
    • 6.14.1 AVERAGE SELLING PRICE OF PHARMACEUTICAL PACKAGING, BY REGION
    • 6.14.2 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY MATERIAL TYPE
    • 6.14.3 INVESTMENT AND FUNDING SCENARIO

7 UNIT DOSE PACKAGING MARKET, BY FORM

  • 7.1 INTRODUCTION
  • 7.2 LIQUID
  • 7.3 SOLID
  • 7.4 POWDER
  • 7.5 GEL

8 UNIT DOSE PACKAGING MARKET, BY MATERIAL TYPE

  • 8.1 INTRODUCTION
  • 8.2 PLASTIC
    • 8.2.1 POLYVINYL CHLORIDE
    • 8.2.2 POLYETHYLENE
    • 8.2.3 POLYPROPYLENE
    • 8.2.4 POLYETHYLENE TEREPHTHALATE
    • 8.2.5 OTHER PLASTIC FILMS
  • 8.3 GLASS
  • 8.4 PAPER & PAPERBOARD
  • 8.5 ALUMINUM
  • 8.6 OTHER MATERIAL TYPES

9 UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE

  • 9.1 INTRODUCTION
  • 9.2 BLISTER PACKS
    • 9.2.1 ENSURE DRUG DOSING ACCURACY AND INCREASED SAFETY
  • 9.3 SACHETS & STRIP PACKS
    • 9.3.1 MAINTAIN PRODUCT FRESHNESS AND QUALITY
  • 9.4 AMPOULES & VIALS
    • 9.4.1 USED FOR STORING AND DISPENSING LIQUID PHARMACEUTICALS
  • 9.5 OTHER PRODUCT TYPES

10 UNIT DOSE PACKAGING, BY END-USE INDUSTRY

  • 10.1 INTRODUCTION
  • 10.2 PHARMACEUTICALS
    • 10.2.1 INCREASED DEMAND FOR PREFILLED SYRINGES AND AUTO-INJECTORS
  • 10.3 COSMETICS & PERSONAL CARE
    • 10.3.1 EXTENDING SHELF LIFE OF BEAUTY PRODUCTS
  • 10.4 NUTRACEUTICALS
    • 10.4.1 ADMINISTRATION OF PRECISE DOSAGE AND CONSUMER COMPLIANCE
  • 10.5 OTHER END-USE INDUSTRIES

11 UNIT DOSE PACKAGING MARKET, BY REGION

  • 11.1 INTRODUCTION
  • 11.2 ASIA PACIFIC
    • 11.2.1 CHINA
      • 11.2.1.1 Rising investments in biologics and biosimilar drug research to drive market
    • 11.2.2 INDIA
      • 11.2.2.1 Large domestic consumption and export of generic drugs to drive market
    • 11.2.3 JAPAN
      • 11.2.3.1 Surge in aging population to drive demand for medications
    • 11.2.4 SOUTH KOREA
      • 11.2.4.1 Growth of cosmetic & personal care industries to drive market
    • 11.2.5 REST OF ASIA PACIFIC
  • 11.3 EUROPE
    • 11.3.1 GERMANY
      • 11.3.1.1 Advanced healthcare infrastructure and emphasis on patient-centric care to drive market
    • 11.3.2 FRANCE
      • 11.3.2.1 Surge in demand for generic drugs to drive market
    • 11.3.3 ITALY
      • 11.3.3.1 Growing exports of pharmaceutical products to boost market
    • 11.3.4 UK
      • 11.3.4.1 Innovations in drug manufacturing to drive market
    • 11.3.5 SPAIN
      • 11.3.5.1 Growth of cosmetic & personal care industry to drive market
    • 11.3.6 REST OF EUROPE
  • 11.4 NORTH AMERICA
    • 11.4.1 US
      • 11.4.1.1 Increasing demand for RFID integration and smart packaging to drive market
    • 11.4.2 CANADA
      • 11.4.2.1 Rising demand for precise packaging to drive market
    • 11.4.3 MEXICO
      • 11.4.3.1 Technological advancements and packaging innovations to boost market
  • 11.5 SOUTH AMERICA
    • 11.5.1 BRAZIL
      • 11.5.1.1 Increased healthcare awareness and substantial investment to drive market
    • 11.5.2 ARGENTINA
      • 11.5.2.1 Innovations in packaging to drive market
    • 11.5.3 REST OF SOUTH AMERICA
  • 11.6 MIDDLE EAST & AFRICA
    • 11.6.1 GCC COUNTRIES
      • 11.6.1.1 Saudi Arabia
        • 11.6.1.1.1 Saudi Vision 2030 to boost demand for advanced medical packaging solutions
      • 11.6.1.2 UAE
        • 11.6.1.2.1 Increasing demand for dietary supplements and functional foods to drive market
      • 11.6.1.3 Rest of GCC countries
    • 11.6.2 SOUTH AFRICA
      • 11.6.2.1 Government initiatives upholding safety and efficacy standards to boost market
    • 11.6.3 REST OF MIDDLE EAST & AFRICA

12 COMPETITIVE LANDSCAPE

  • 12.1 OVERVIEW
  • 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • 12.3 REVENUE ANALYSIS
  • 12.4 MARKET SHARE ANALYSIS
  • 12.5 COMPANY VALUATION AND FINANCIAL METRICS
  • 12.6 PRODUCT/BRAND COMPARISON ANALYSIS
  • 12.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    • 12.7.1 STARS
    • 12.7.2 EMERGING LEADERS
    • 12.7.3 PERVASIVE PLAYERS
    • 12.7.4 PARTICIPANTS
    • 12.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
      • 12.7.5.1 Company footprint
      • 12.7.5.2 Form footprint
      • 12.7.5.3 Material type footprint
      • 12.7.5.4 Product type footprint
      • 12.7.5.5 End-use industry footprint
      • 12.7.5.6 Region footprint
  • 12.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    • 12.8.1 PROGRESSIVE COMPANIES
    • 12.8.2 RESPONSIVE COMPANIES
    • 12.8.3 DYNAMIC COMPANIES
    • 12.8.4 STARTING BLOCKS
    • 12.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
  • 12.9 COMPETITIVE SCENARIO AND TRENDS
    • 12.9.1 PRODUCT LAUNCHES
    • 12.9.2 DEALS
    • 12.9.3 EXPANSIONS

13 COMPANY PROFILES

  • 13.1 KEY PLAYERS
    • 13.1.1 PFIZER INC.
      • 13.1.1.1 Business overview
      • 13.1.1.2 Products/Solutions/Services offered
      • 13.1.1.3 Recent developments
        • 13.1.1.3.1 Product launches
        • 13.1.1.3.2 Deals
      • 13.1.1.4 MnM view
        • 13.1.1.4.1 Right to win
        • 13.1.1.4.2 Strategic choices
        • 13.1.1.4.3 Weaknesses & competitive threats
    • 13.1.2 AMCOR PLC
      • 13.1.2.1 Business overview
      • 13.1.2.2 Products/Solutions/Services offered
      • 13.1.2.3 Recent developments
        • 13.1.2.3.1 Product launches
        • 13.1.2.3.2 Expansion
      • 13.1.2.4 MnM view
        • 13.1.2.4.1 Right to win
        • 13.1.2.4.2 Strategic choices
        • 13.1.2.4.3 Weaknesses & competitive threats
    • 13.1.3 CORNING INCORPORATED
      • 13.1.3.1 Business overview
      • 13.1.3.2 Products/Solutions/Services offered
      • 13.1.3.3 Recent developments
        • 13.1.3.3.1 Product launches
        • 13.1.3.3.2 Deals
      • 13.1.3.4 MnM view
        • 13.1.3.4.1 Right to win
        • 13.1.3.4.2 Strategic choices
        • 13.1.3.4.3 Weaknesses & competitive threats
    • 13.1.4 WEST PHARMACEUTICAL SERVICES
      • 13.1.4.1 Business overview
      • 13.1.4.2 Products/Solutions/Services offered
      • 13.1.4.3 Recent developments
        • 13.1.4.3.1 Product launches
        • 13.1.4.3.2 Deals
        • 13.1.4.3.3 Expansion
      • 13.1.4.4 MnM view
        • 13.1.4.4.1 Right to win
        • 13.1.4.4.2 Strategic choices
        • 13.1.4.4.3 Weaknesses & competitive threats
    • 13.1.5 STEVANATO GROUP
      • 13.1.5.1 Business overview
      • 13.1.5.2 Products/Solutions/Services offered
      • 13.1.5.3 Recent developments
        • 13.1.5.3.1 Product launches
        • 13.1.5.3.2 Deals
        • 13.1.5.3.3 Expansion
      • 13.1.5.4 MnM view
        • 13.1.5.4.1 Right to win
        • 13.1.5.4.2 Strategic choices
        • 13.1.5.4.3 Weaknesses & competitive threats
    • 13.1.6 GERRESHEIMER AG
      • 13.1.6.1 Business overview
      • 13.1.6.2 Products/Solutions/Services offered
      • 13.1.6.3 Recent developments
        • 13.1.6.3.1 Product launches
        • 13.1.6.3.2 Deals
        • 13.1.6.3.3 Expansion
      • 13.1.6.4 MnM view
    • 13.1.7 SCHOTT
      • 13.1.7.1 Business overview
      • 13.1.7.2 Products/Solutions/Services offered
      • 13.1.7.3 Recent developments
        • 13.1.7.3.1 Product launches
        • 13.1.7.3.2 Deals
        • 13.1.7.3.3 Expansion
      • 13.1.7.4 MnM view
    • 13.1.8 NIPRO
      • 13.1.8.1 Business overview
      • 13.1.8.2 Products/Solutions/Services offered
      • 13.1.8.3 Recent developments
        • 13.1.8.3.1 Product launches
      • 13.1.8.4 MnM view
    • 13.1.9 CONSTANTIA FLEXIBLES
      • 13.1.9.1 Business overview
      • 13.1.9.2 Products/Solutions/Services offered
      • 13.1.9.3 Recent developments
        • 13.1.9.3.1 Deals
        • 13.1.9.3.2 Expansion
      • 13.1.9.4 MnM view
    • 13.1.10 KLOCKNER PENTAPLAST
      • 13.1.10.1 Business overview
      • 13.1.10.2 Products/Solutions/Services offered
      • 13.1.10.3 Recent developments
        • 13.1.10.3.1 Expansion
      • 13.1.10.4 MnM view
  • 13.2 OTHER PLAYERS
    • 13.2.1 SONIC PACKAGING INDUSTRIES INC.
    • 13.2.2 SHARP SERVICES, LLC
    • 13.2.3 TEKNI-PLEX, INC.
    • 13.2.4 THERMO-PAK CO. INC.
    • 13.2.5 APHENA PHARMA SOLUTIONS
    • 13.2.6 PACIFIC VIAL MANUFACTURING INC.
    • 13.2.7 HEALTH CARE LOGISTICS, INC.
    • 13.2.8 ULTRA SEAL CORPORATION
    • 13.2.9 SAFECORE HEALTH
    • 13.2.10 UNIT PACK
    • 13.2.11 JONES HEALTHCARE GROUP
    • 13.2.12 ROPACK INC.
    • 13.2.13 RX SYSTEMS, INC.
    • 13.2.14 JAMES ALEXANDER CORPORATION
    • 13.2.15 PHARMACY AUTOMATION SUPPLIES

14 ADJACENT & RELATED MARKETS

  • 14.1 INTRODUCTION
  • 14.2 LIMITATIONS
    • 14.2.1 PHARMACEUTICAL PACKAGING MARKET
      • 14.2.1.1 Market definition
      • 14.2.1.2 Pharmaceutical packaging market, by packaging type
      • 14.2.1.3 Pharmaceutical packaging market, by raw material
      • 14.2.1.4 Pharmaceutical packaging market, by drug delivery
      • 14.2.1.5 Pharmaceutical packaging market, by type
      • 14.2.1.6 Pharmaceutical packaging market, by region
    • 14.2.2 NUTRACEUTICAL PACKAGING MARKET
      • 14.2.2.1 Market definition
      • 14.2.2.2 Nutraceutical packaging market, by product form
      • 14.2.2.3 Nutraceutical packaging market, by product type
      • 14.2.2.4 Nutraceutical packaging market, by packaging type
      • 14.2.2.5 Nutraceutical packaging market, by material
      • 14.2.2.6 Nutraceutical packaging market, by ingredient
      • 14.2.2.7 Nutraceutical packaging market, by region

15 APPENDIX

  • 15.1 DISCUSSION GUIDE
  • 15.2 CUSTOMIZATION OPTIONS
  • 15.3 RELATED REPORTS
  • 15.4 AUTHOR DETAILS

List of Tables

  • TABLE 1 UNIT DOSE PACKAGING MARKET: PORTER'S FIVE FORCES ANALYSIS
  • TABLE 2 WORLD GDP GROWTH PROJECTION, 2019-2026 (USD BILLION)
  • TABLE 3 AVERAGE TARIFF BY COUNTRY
  • TABLE 4 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 5 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 6 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 7 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 8 SOUTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 9 PFIZER-ENHANCING MEDICATION COMPLIANCE IN ELDERLY PATIENTS
  • TABLE 10 WESTROCK COMPANY-IMPROVING OPERATIONAL EFFICIENCY IN UNIT DOSE PACKAGING PRODUCTION
  • TABLE 11 SHARP PACKAGING SOLUTIONS-INTEGRATING SMART TECHNOLOGY TO IMPROVE PATIENT ADHERENCE
  • TABLE 12 UNIT DOSE PACKAGING MARKET: KEY CONFERENCES & EVENTS, 2024-2025
  • TABLE 13 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR UNIT DOSE PACKAGING MARKET
  • TABLE 14 KEY BUYING CRITERIA FOR TOP 3 END-USE INDUSTRIES
  • TABLE 15 UNIT DOSE PACKAGING MARKET: ROLE OF PLAYERS IN ECOSYSTEM
  • TABLE 16 PATENTS IN UNIT DOSE PACKAGING MARKET, 2022-2023
  • TABLE 17 AVERAGE SELLING PRICE OF MATERIAL TYPE, BY KEY PLAYER, 2023 (USD/TON)
  • TABLE 18 UNIT DOSE PACKAGING MARKET, BY FORM, 2022-2029 (USD BILLION)
  • TABLE 19 UNIT DOSE PACKAGING MARKET, BY MATERIAL TYPE, 2022-2029 (USD BILLION)
  • TABLE 20 UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE, 2022-2029 (USD BILLION)
  • TABLE 21 UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY, 2022-2029 (USD BILLION)
  • TABLE 22 UNIT DOSE PACKAGING MARKET, BY REGION, 2022-2029 (USD BILLION)
  • TABLE 23 ASIA PACIFIC: UNIT DOSE PACKAGING MARKET, BY COUNTRY, 2022-2029 (USD BILLION)
  • TABLE 24 ASIA PACIFIC: UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE, 2022-2029 (USD BILLION)
  • TABLE 25 ASIA PACIFIC: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY, 2022-2029 (USD BILLION)
  • TABLE 26 CHINA: UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE, 2022-2029 (USD BILLION)
  • TABLE 27 CHINA: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY, 2022-2029 (USD BILLION)
  • TABLE 28 INDIA: UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE, 2022-2029 (USD BILLION)
  • TABLE 29 INDIA: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY, 2022-2029 (USD BILLION)
  • TABLE 30 JAPAN: UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE, 2022-2029 (USD BILLION)
  • TABLE 31 JAPAN: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY, 2022-2029 (USD BILLION)
  • TABLE 32 SOUTH KOREA: UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE, 2022-2029 (USD BILLION)
  • TABLE 33 SOUTH KOREA: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY, 2022-2029 (USD BILLION)
  • TABLE 34 REST OF ASIA PACIFIC: UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE, 2022-2029 (USD BILLION)
  • TABLE 35 REST OF ASIA PACIFIC: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY, 2022-2029 (USD BILLION)
  • TABLE 36 EUROPE: UNIT DOSE PACKAGING MARKET, BY COUNTRY, 2022-2029 (USD BILLION)
  • TABLE 37 EUROPE: UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE, 2022-2029 (USD BILLION)
  • TABLE 38 EUROPE: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY, 2022-2029 (USD BILLION)
  • TABLE 39 GERMANY: UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE, 2022-2029 (USD BILLION)
  • TABLE 40 GERMANY: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY, 2022-2029 (USD BILLION)
  • TABLE 41 FRANCE: UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE, 2022-2029 (USD BILLION)
  • TABLE 42 FRANCE: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY, 2022-2029 (USD BILLION)
  • TABLE 43 ITALY: UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE, 2022-2029 (USD BILLION)
  • TABLE 44 ITALY: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY, 2022-2029 (USD BILLION)
  • TABLE 45 UK: UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE, 2022-2029 (USD BILLION)
  • TABLE 46 UK: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY, 2022-2029 (USD BILLION)
  • TABLE 47 SPAIN: UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE, 2022-2029 (USD BILLION)
  • TABLE 48 SPAIN: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY, 2022-2029 (USD BILLION)
  • TABLE 49 REST OF EUROPE: UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE, 2022-2029 (USD BILLION)
  • TABLE 50 REST OF EUROPE: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY, 2022-2029 (USD BILLION)
  • TABLE 51 NORTH AMERICA: UNIT DOSE PACKAGING MARKET, BY COUNTRY, 2022-2029 (USD BILLION)
  • TABLE 52 NORTH AMERICA: UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE, 2022-2029 (USD BILLION)
  • TABLE 53 NORTH AMERICA: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY, 2022-2029 (USD BILLION)
  • TABLE 54 US: UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE, 2022-2029 (USD BILLION)
  • TABLE 55 US: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY, 2022-2029 (USD BILLION)
  • TABLE 56 CANADA: UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE, 2022-2029 (USD BILLION)
  • TABLE 57 CANADA: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY, 2022-2029 (USD BILLION)
  • TABLE 58 MEXICO: UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE, 2022-2029 (USD BILLION)
  • TABLE 59 MEXICO: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY, 2022-2029 (USD BILLION)
  • TABLE 60 SOUTH AMERICA: UNIT DOSE PACKAGING MARKET, BY COUNTRY, 2022-2029 (USD BILLION)
  • TABLE 61 SOUTH AMERICA: UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE, 2022-2029 (USD BILLION)
  • TABLE 62 SOUTH AMERICA: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY, 2022-2029 (USD BILLION)
  • TABLE 63 BRAZIL: UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE, 2022-2029 (USD BILLION)
  • TABLE 64 BRAZIL: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY, 2022-2029 (USD BILLION)
  • TABLE 65 ARGENTINA: UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE, 2022-2029 (USD BILLION)
  • TABLE 66 ARGENTINA: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY, 2022-2029 (USD BILLION)
  • TABLE 67 REST OF SOUTH AMERICA: UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE, 2022-2029 (USD BILLION)
  • TABLE 68 REST OF SOUTH AMERICA: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY, 2022-2029 (USD BILLION)
  • TABLE 69 MIDDLE EAST & AFRICA: UNIT DOSE PACKAGING MARKET, BY COUNTRY, 2022-2029 (USD BILLION)
  • TABLE 70 MIDDLE EAST & AFRICA: UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE, 2022-2029 (USD BILLION)
  • TABLE 71 MIDDLE EAST & AFRICA: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY, 2022-2029 (USD BILLION)
  • TABLE 72 GCC COUNTRIES: UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE, 2022-2029 (USD BILLION)
  • TABLE 73 GCC COUNTRIES: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY, 2022-2029 (USD BILLION)
  • TABLE 74 SAUDI ARABIA: UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE, 2022-2029 (USD BILLION)
  • TABLE 75 SAUDI ARABIA: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY, 2022-2029 (USD BILLION)
  • TABLE 76 UAE: UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE, 2022-2029 (USD BILLION)
  • TABLE 77 UAE: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY, 2022-2029 (USD BILLION)
  • TABLE 78 REST OF GCC COUNTRIES: UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE, 2022-2029 (USD BILLION)
  • TABLE 79 REST OF GCC COUNTRIES: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY, 2022-2029 (USD BILLION)
  • TABLE 80 SOUTH AFRICA: UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE, 2022-2029 (USD BILLION)
  • TABLE 81 SOUTH AFRICA: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY, 2022-2029 (USD BILLION)
  • TABLE 82 REST OF MIDDLE EAST & AFRICA: UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE, 2022-2029 (USD BILLION)
  • TABLE 83 REST OF MIDDLE EAST & AFRICA: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY, 2022-2029 (USD BILLION)
  • TABLE 84 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN UNIT DOSAGE PACKAGING MARKET
  • TABLE 85 UNIT DOSE PACKAGING MARKET: DEGREE OF COMPETITION
  • TABLE 86 UNIT DOSE PACKAGING MARKET: FORM FOOTPRINT
  • TABLE 87 UNIT DOSE PACKAGING MARKET: MATERIAL TYPE FOOTPRINT
  • TABLE 88 UNIT DOSE PACKAGING MARKET: PRODUCT TYPE FOOTPRINT
  • TABLE 89 UNIT DOSE PACKAGING MARKET: END-USE INDUSTRY FOOTPRINT
  • TABLE 90 UNIT DOSE PACKAGING MARKET: REGION FOOTPRINT
  • TABLE 91 UNIT DOSE PACKAGING MARKET: KEY STARTUPS/SMES
  • TABLE 92 UNIT DOSE PACKAGING MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
  • TABLE 93 UNIT DOSE PACKAGING MARKET: PRODUCT LAUNCHES, JANUARY 2018-MAY 2024
  • TABLE 94 UNIT DOSE PACKAGING MARKET: DEALS, JANUARY 2018-MAY 2024
  • TABLE 95 UNIT DOSE PACKAGING MARKET: EXPANSIONS, JANUARY 2018-MAY 2024
  • TABLE 96 PFIZER INC.: COMPANY OVERVIEW
  • TABLE 97 PFIZER INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 98 PFIZER INC.: PRODUCT LAUNCHES, JANUARY 2018-MAY 2024
  • TABLE 99 PFIZER INC.: DEALS, JANUARY 2018-MAY 2024
  • TABLE 100 AMCOR PLC: COMPANY OVERVIEW
  • TABLE 101 AMCOR PLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 102 AMCOR PLC: PRODUCT LAUNCHES, JANUARY 2018-MAY 2024
  • TABLE 103 AMCOR PLC: EXPANSION, JANUARY 2018-MAY 2024
  • TABLE 104 CORNING INCORPORATED: COMPANY OVERVIEW
  • TABLE 105 CORNING INCORPORATED: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 106 CORNING INCORPORATED: PRODUCT LAUNCHES, JANUARY 2018-MAY 2024
  • TABLE 107 CORNING INCORPORATED: DEALS, JANUARY 2018-MAY 2024
  • TABLE 108 WEST PHARMACEUTICAL SERVICES: COMPANY OVERVIEW
  • TABLE 109 WEST PHARMACEUTICAL SERVICES: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 110 WEST PHARMACEUTICAL SERVICES: PRODUCT LAUNCHES, JANUARY 2018-MAY 2024
  • TABLE 111 WEST PHARMACEUTICAL SERVICES: DEALS, JANUARY 2018-MAY 2024
  • TABLE 112 WEST PHARMACEUTICAL SERVICES: EXPANSION, JANUARY 2018-MAY 2024
  • TABLE 113 STEVANATO GROUP: COMPANY OVERVIEW
  • TABLE 114 STEVANATO GROUP: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 115 STEVANATO GROUP: PRODUCT LAUNCHES, JANUARY 2018-MAY 2024
  • TABLE 116 STEVANATO GROUP: DEALS, JANUARY 2018-MAY 2024
  • TABLE 117 STEVANATO GROUP: EXPANSION, JANUARY 2018-MAY 2024
  • TABLE 118 GERRESHEIMER AG: COMPANY OVERVIEW
  • TABLE 119 GERRESHEIMER AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 120 GERRESHEIMER AG: PRODUCT LAUNCHES, JANUARY 2018-MAY 2024
  • TABLE 121 GERRESHEIMER AG: DEALS, JANUARY 2018-MAY 2024
  • TABLE 122 GERRESHEIMER AG: EXPANSION, JANUARY 2018-MAY 2024
  • TABLE 123 SCHOTT: COMPANY OVERVIEW
  • TABLE 124 SCHOTT: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 125 SCHOTT: PRODUCT LAUNCHES, JANUARY 2018-MAY 2024
  • TABLE 126 SCHOTT: DEALS, JANUARY 2018-MAY 2024
  • TABLE 127 SCHOTT: EXPANSION, JANUARY 2018-MAY 2024
  • TABLE 128 NIPRO: COMPANY OVERVIEW
  • TABLE 129 NIPRO: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 130 NIPRO: PRODUCT LAUNCHES, JANUARY 2018-MAY 2024
  • TABLE 131 CONSTANTIA FLEXIBLES: COMPANY OVERVIEW
  • TABLE 132 CONSTANTIA FLEXIBLES: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 133 CONSTANTIA FLEXIBLES: DEALS, JANUARY 2018-MAY 2024
  • TABLE 134 CONSTANTIA FLEXIBLES: EXPANSION, JANUARY 2018-MAY 2024
  • TABLE 135 KLOCKNER PENTAPLAST: COMPANY OVERVIEW
  • TABLE 136 KLOCKNER PENTAPLAST: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 137 KLOCKNER PENTAPLAST: EXPANSION, JANUARY 2018-MAY 2024
  • TABLE 138 PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2020-2022 (USD MILLION)
  • TABLE 139 PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2023-2028 (USD MILLION)
  • TABLE 140 PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020-2022 (KILOTON)
  • TABLE 141 PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2023-2028 (KILOTON)
  • TABLE 142 PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020-2022 (USD MILLION)
  • TABLE 143 PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2023-2028 (USD MILLION)
  • TABLE 144 DRUG DELIVERY: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020-2022 (USD MILLION)
  • TABLE 145 DRUG DELIVERY: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023-2028 (USD MILLION)
  • TABLE 146 PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2020-2022 (USD MILLION)
  • TABLE 147 PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2023-2028 (USD MILLION)
  • TABLE 148 PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020-2022 (USD MILLION)
  • TABLE 149 PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023-2028 (USD MILLION)
  • TABLE 150 PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020-2022 (USD MILLION)
  • TABLE 151 PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023-2028 (USD MILLION)
  • TABLE 152 NUTRACEUTICAL PACKAGING MARKET, BY PRODUCT FORM, 2019-2022 (USD MILLION)
  • TABLE 153 NUTRACEUTICAL PACKAGING MARKET, BY PRODUCT FORM, 2023-2028 (USD MILLION)
  • TABLE 154 NUTRACEUTICAL PACKAGING MARKET, BY PRODUCT TYPE, 2019-2022 (USD MILLION)
  • TABLE 155 NUTRACEUTICAL PACKAGING MARKET, BY PRODUCT TYPE, 2023-2028 (USD MILLION)
  • TABLE 156 NUTRACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2019-2022 (USD MILLION)
  • TABLE 157 NUTRACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2023-2028 (USD MILLION)
  • TABLE 158 NUTRACEUTICAL PACKAGING MARKET, BY MATERIAL, 2019-2022 (USD MILLION)
  • TABLE 159 NUTRACEUTICAL PACKAGING MARKET, BY MATERIAL, 2023-2028 (USD MILLION)
  • TABLE 160 NUTRACEUTICAL PACKAGING MARKET, BY MATERIAL, 2019-2022 (KILOTON)
  • TABLE 161 NUTRACEUTICAL PACKAGING MARKET, BY MATERIAL, 2023-2028 (KILOTON)
  • TABLE 162 NUTRACEUTICAL PACKAGING MARKET, BY INGREDIENT, 2019-2022 (USD MILLION)
  • TABLE 163 NUTRACEUTICAL PACKAGING MARKET, BY INGREDIENT, 2023-2028 (USD MILLION)
  • TABLE 164 NUTRACEUTICAL PACKAGING MARKET, BY REGION, 2019-2022 (USD MILLION)
  • TABLE 165 NUTRACEUTICAL PACKAGING MARKET, BY REGION, 2023-2028 (USD MILLION)

List of Figures

  • FIGURE 1 UNIT DOSE PACKAGING: RESEARCH DESIGN
  • FIGURE 2 UNIT DOSE PACKAGING MARKET: TOP-DOWN APPROACH
  • FIGURE 3 UNIT DOSE PACKAGING MARKET: APPROACH 1
  • FIGURE 4 UNIT DOSE PACKAGING MARKET: APPROACH 2
  • FIGURE 5 UNIT DOSE PACKAGING MARKET: DATA TRIANGULATION
  • FIGURE 6 LIQUID FORM SEGMENT TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 7 PLASTIC SEGMENT TO WITNESS HIGHEST GROWTH RATE DURING FORECAST PERIOD
  • FIGURE 8 BLISTER PACKS TO WITNESS HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 9 PHARMACEUTICALS TO BE LARGEST END-USE INDUSTRY DURING FORECAST PERIOD
  • FIGURE 10 NORTH AMERICA TO LEAD MARKET DURING FORECAST PERIOD
  • FIGURE 11 EMERGING ECONOMIES OFFER ATTRACTIVE OPPORTUNITIES IN UNIT DOSE PACKAGING MARKET
  • FIGURE 12 US DOMINATED UNIT DOSE PACKAGING MARKET IN 2023
  • FIGURE 13 BLISTER PACKS TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
  • FIGURE 14 PHARMACEUTICALS TO LEAD UNIT DOSE PACKAGING MARKET DURING FORECAST PERIOD
  • FIGURE 15 CHINA PROJECTED TO GROW AT HIGHEST CAGR FROM 2024 TO 2029
  • FIGURE 16 UNIT DOSE PACKAGING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 17 VALUE FORECAST OF PHARMACEUTICAL EMPTY CAPSULES MARKET WORLDWIDE FROM 2021 TO 2032, BY RAW MATERIALS (USD MILLION)
  • FIGURE 18 UNIT DOSE PACKAGING MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 19 UNIT DOSE PACKAGING: VALUE CHAIN ANALYSIS
  • FIGURE 20 EXPORT OF "3923 ARTICLES FOR THE CONVEYANCE OR PACKAGING OF GOODS, OF PLASTICS; STOPPERS, LIDS, CAPS, AND OTHER CLOSURES, OF PLASTICS," BY KEY COUNTRY, 2019-2023
  • FIGURE 21 IMPORT OF 280610 "3923 ARTICLES FOR THE CONVEYANCE OR PACKAGING OF GOODS, OF PLASTICS; STOPPERS, LIDS, CAPS, AND OTHER CLOSURES, OF PLASTICS," BY KEY COUNTRY, 2019-2023
  • FIGURE 22 EMERGING TRENDS AND ADVANCEMENTS IN TECHNOLOGY TO CHANGE FUTURE REVENUE MIX OF SUPPLIERS
  • FIGURE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP 3 END-USE INDUSTRIES
  • FIGURE 24 KEY BUYING CRITERIA FOR TOP 3 END-USE INDUSTRIES
  • FIGURE 25 UNIT DOSE PACKAGING MARKET: ECOSYSTEM
  • FIGURE 26 NUMBER OF PATENTS GRANTED FOR UNIT DOSE PACKAGING, 2013-2023
  • FIGURE 27 REGIONAL ANALYSIS OF PATENTS GRANTED FOR UNIT DOSE PACKAGING, 2013-2023
  • FIGURE 28 AVERAGE SELLING PRICE OF PHARMACEUTICAL PACKAGING, BY REGION (USD/KG)
  • FIGURE 29 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY MATERIAL TYPE (USD/KG)
  • FIGURE 30 INVESTOR DEALS AND FUNDING IN UNIT DOSE PACKAGING SOARED IN 2023
  • FIGURE 31 LIQUID SEGMENT TO REGISTER HIGHEST GROWTH THROUGH 2029
  • FIGURE 32 PLASTICS SEGMENT TO REGISTER HIGHEST CAGR THROUGH 2029
  • FIGURE 33 BLISTER PACKS SEGMENT TO RECORD HIGHEST GROWTH THROUGH 2029
  • FIGURE 34 PHARMACEUTICALS INDUSTRY TO BE LARGEST CONSUMER OF UNIT DOSE PACKAGING
  • FIGURE 35 UNIT DOSE PACKAGING MARKET GROWTH RATE, BY COUNTRY, 2024-2029
  • FIGURE 36 ASIA PACIFIC: UNIT DOSE PACKAGING MARKET SNAPSHOT
  • FIGURE 37 EUROPE: UNIT DOSE PACKAGING MARKET SNAPSHOT
  • FIGURE 38 NORTH AMERICA: UNIT DOSE PACKAGING MARKET SNAPSHOT
  • FIGURE 39 REVENUE ANALYSIS OF KEY COMPANIES IN LAST FIVE YEARS
  • FIGURE 40 UNIT DOSE PACKAGING MARKET: MARKET SHARE ANALYSIS
  • FIGURE 41 COMPANY VALUATION (USD BILLION)
  • FIGURE 42 FINANCIAL MATRIX: EV/EBITDA RATIO
  • FIGURE 43 PRODUCT COMPARISON
  • FIGURE 44 UNIT DOSE PACKAGING MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 45 UNIT DOSE PACKAGING MARKET: COMPANY FOOTPRINT
  • FIGURE 46 UNIT DOSE PACKAGING MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 47 PFIZER INC.: COMPANY SNAPSHOT
  • FIGURE 48 AMCOR PLC: COMPANY SNAPSHOT
  • FIGURE 49 CORNING INCORPORATED: COMPANY SNAPSHOT
  • FIGURE 50 WEST PHARMACEUTICAL SERVICES: COMPANY SNAPSHOT
  • FIGURE 51 STEVANATO GROUP: COMPANY SNAPSHOT
  • FIGURE 52 GERRESHEIMER AG: COMPANY SNAPSHOT
  • FIGURE 53 NIPRO: COMPANY SNAPSHOT